Skip to main content
. 2021 Nov 17;13(22):5757. doi: 10.3390/cancers13225757

Scheme 3.

Scheme 3

Synthesis of cysteine-based analogs lacking the polyisoprenyl moiety (NSL-YHJ-2-62).